Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) has issued an update.
Shanghai Bio-heart Biological Technology Co., Ltd. announced a voluntary update regarding its proposal to repurchase and cancel H shares as part of its 2022 H Share Incentive Scheme. The company received a waiver from compliance with certain requirements of the Share Buy-backs Code for this off-market share buy-back, which is subject to shareholder approval at the upcoming annual general meeting. Stakeholders are advised to exercise caution when dealing with the company’s shares.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-heart Biological Technology Co., Ltd. operates in the biotechnology industry, focusing on the development and commercialization of innovative biological products. The company is incorporated in the People’s Republic of China and is listed on the Hong Kong Stock Exchange, with a primary market focus on biological technology advancements.
Average Trading Volume: 280,408
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.09B
For an in-depth examination of 2185 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue